John S Santelli1, Ivy S Chen2, Dorean Nabukalu3, Tom Lutalo3, Esther J Spindler4, Larry W Chang5, Mary Kate Grabowski6, Stephanie A Grilo4, Philip Kreniske7, Ying Wei2, Fred Nalugoda3, Susie Hoffman8, Mahlet Maru9, Sofia Chu4, Fred M Ssewamala10, William Byansi10, Joseph Kagaayi11, Maria J Wawer5, Ronald H Gray12, David Serwadda13, Fred Makumbi11. 1. Heilbrunn Department of Population and Family Health, Columbia University, New York, NY, USA; Mailman School of Public Health and Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. Electronic address: js2637@columbia.edu. 2. Department of Biostatistics, Columbia University, New York, NY, USA. 3. Rakai Health Sciences Program, Kalisizo, Uganda. 4. Heilbrunn Department of Population and Family Health, Columbia University, New York, NY, USA. 5. Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 6. Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Pathology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA. 8. Department of Epidemiology, Columbia University, New York, NY, USA; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA. 9. Department of Sociomedical Sciences, Columbia University, New York, NY, USA. 10. Brown School, Washington University, St Louis, MO, USA. 11. Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda. 12. Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 13. Rakai Health Sciences Program, Kalisizo, Uganda; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Abstract
BACKGROUND: Orphanhood increased markedly in the 1980s and 1990s in sub-Saharan Africa because of HIV-related mortality. Little is known about the contribution of HIV interventions, such as antiretroviral therapy (ART) and male medical circumcision, to more recent trends in orphanhood. In this study, we examined trends over time in maternal-only, paternal-only, and double orphanhood among adolescents before and after ART and male medical circumcision became widely available in the Rakai region of south-central Uganda. We sought to understand the association between adolescent orphanhood and HIV combination prevention (community-level ART use and prevalence of male medical circumcision). We hypothesised that increasing combination prevention, including greater use of ART and higher prevalence of male medical circumcision, would be associated with a lower probability of orphanhood. METHODS: We examined the prevalence of orphanhood among adolescents aged 15-19 years, before and after roll-out of ART in mid-2004 and male medical circumcision in 2007, using data from 28 continuously followed communities within the Rakai Community Cohort Study. We used multinomial logistic regression with clustered SEs to estimate adjusted relative risk ratios (RRs) for maternal-only, paternal-only, and double orphanhood compared with non-orphanhood over 11 survey rounds between 2001 and 2018. Controlling for community HIV prevalence, household socioeconomic status, and adolescent age, we examined the association between community prevalence of ART use among people living with HIV and prevalence of male circumcision, including traditional circumcision. The primary outcome was orphanhood among adolescents aged 15-19 years. FINDINGS: Orphanhood declined from 52% (920 of 1768 participants) in 2001-02 to 23% (592 of 2609 participants) by 2016-18 (p<0·0001), while double orphanhood declined from 20% (346 of 1768 participants) to 3% (86 of 2609 participants) (p<0·0001). Community prevalence of ART use among people living with HIV increased from 11% (105 of 945 participants) in 2005-06 to 78% (1163 of 1485 participants) in 2016-18. Male circumcision rates rose from 19% (147 of 790 participants) in 2005-06 to 65% (3535 of 5433 participants) in 2016-18. In the multinomial logistic regression model, a 10% increase in community prevalence of ART use was associated with a decrease in maternal orphanhood (adjusted relative RR 0·90, 95% CI 0·85-0·95) and double orphanhood (0·80, 0·75-0·85). In the post-ART era, a 10% increase in the community prevalence of male circumcision was associated with a decrease in paternal orphanhood (2005-18, adjusted relative RR 0·92, 0·87-0·97) and double orphanhood (0·91, 0·85-0·98). INTERPRETATION: Widespread availability and uptake of HIV combination prevention was associated with marked reductions in orphanhood among adolescents. Reductions in orphanhood promise improved health and social outcomes for young people. FUNDING: Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the Division of Intramural Research of the National Institute for Allergy and Infectious Diseases.
BACKGROUND: Orphanhood increased markedly in the 1980s and 1990s in sub-Saharan Africa because of HIV-related mortality. Little is known about the contribution of HIV interventions, such as antiretroviral therapy (ART) and male medical circumcision, to more recent trends in orphanhood. In this study, we examined trends over time in maternal-only, paternal-only, and double orphanhood among adolescents before and after ART and male medical circumcision became widely available in the Rakai region of south-central Uganda. We sought to understand the association between adolescent orphanhood and HIV combination prevention (community-level ART use and prevalence of male medical circumcision). We hypothesised that increasing combination prevention, including greater use of ART and higher prevalence of male medical circumcision, would be associated with a lower probability of orphanhood. METHODS: We examined the prevalence of orphanhood among adolescents aged 15-19 years, before and after roll-out of ART in mid-2004 and male medical circumcision in 2007, using data from 28 continuously followed communities within the Rakai Community Cohort Study. We used multinomial logistic regression with clustered SEs to estimate adjusted relative risk ratios (RRs) for maternal-only, paternal-only, and double orphanhood compared with non-orphanhood over 11 survey rounds between 2001 and 2018. Controlling for community HIV prevalence, household socioeconomic status, and adolescent age, we examined the association between community prevalence of ART use among people living with HIV and prevalence of male circumcision, including traditional circumcision. The primary outcome was orphanhood among adolescents aged 15-19 years. FINDINGS: Orphanhood declined from 52% (920 of 1768 participants) in 2001-02 to 23% (592 of 2609 participants) by 2016-18 (p<0·0001), while double orphanhood declined from 20% (346 of 1768 participants) to 3% (86 of 2609 participants) (p<0·0001). Community prevalence of ART use among people living with HIV increased from 11% (105 of 945 participants) in 2005-06 to 78% (1163 of 1485 participants) in 2016-18. Male circumcision rates rose from 19% (147 of 790 participants) in 2005-06 to 65% (3535 of 5433 participants) in 2016-18. In the multinomial logistic regression model, a 10% increase in community prevalence of ART use was associated with a decrease in maternal orphanhood (adjusted relative RR 0·90, 95% CI 0·85-0·95) and double orphanhood (0·80, 0·75-0·85). In the post-ART era, a 10% increase in the community prevalence of male circumcision was associated with a decrease in paternal orphanhood (2005-18, adjusted relative RR 0·92, 0·87-0·97) and double orphanhood (0·91, 0·85-0·98). INTERPRETATION: Widespread availability and uptake of HIV combination prevention was associated with marked reductions in orphanhood among adolescents. Reductions in orphanhood promise improved health and social outcomes for young people. FUNDING: Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the Division of Intramural Research of the National Institute for Allergy and Infectious Diseases.
Authors: Joseph Kagaayi; Larry W Chang; Victor Ssempijja; M Kate Grabowski; Robert Ssekubugu; Gertrude Nakigozi; Godfrey Kigozi; David M Serwadda; Ronald H Gray; Fred Nalugoda; Nelson K Sewankambo; Lisa Nelson; Lisa A Mills; Donna Kabatesi; Stella Alamo; Caitlin E Kennedy; Aaron A R Tobian; John S Santelli; Anna Mia Ekström; Helena Nordenstedt; Thomas C Quinn; Maria J Wawer; Steven J Reynolds Journal: Lancet HIV Date: 2019-09-15 Impact factor: 12.767
Authors: Fredrick E Makumbi; Ronald H Gray; David Serwadda; Fred Nalugoda; Mohamed Kiddugavu; Nelson K Sewankambo; Fred Wabwire-Mangen; Maria J Wawer Journal: AIDS Date: 2005-10-14 Impact factor: 4.177
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jonathan Mermin; Willy Were; John Paul Ekwaru; David Moore; Robert Downing; Prosper Behumbiize; John R Lule; Alex Coutinho; Jordan Tappero; Rebecca Bunnell Journal: Lancet Date: 2008-03-01 Impact factor: 79.321
Authors: Ronald H Gray; Xianbin Li; Godfrey Kigozi; David Serwadda; Fred Nalugoda; Stephen Watya; Steven J Reynolds; Maria Wawer Journal: AIDS Date: 2007-04-23 Impact factor: 4.177
Authors: A Goga; A Slogrove; C J Wedderburn; U Feucht; J Wessels; V Ramokolo; A Bhana; N Du Plessis; R J Green; Y Pillay; G Sherman Journal: S Afr Med J Date: 2019-12-05